By combining multi-omics technologies such as metabolomics, single-cell transcriptomics and spatial omics, we systematically depict the dynamic changes of GSH in different tissues (such as liver, brain, tumor tissue, etc.) and under different disease states (such as normal, inflammatory, cancerous, etc.), and deeply analyze the functional mechanism of GSH in different physiological and pathological backgrounds, providing a more comprehensive theoretical basis for the diagnosis, treatment and prognosis of diseases
TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)
The roles of lactate and the interplay with m6A modification in diseases
Chen K, Yu Y, Wang Y, Zhu Y, Qin C, Xu J, et al